Citalopram
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
87063-221 -
Package NDC
87063-221-01 -
Package NDC
87063-221-10 -
Package NDC
87063-221-20 -
Package NDC
87063-221-30 -
Package NDC
87063-221-60 -
Package NDC
87063-221-90 -
Application number
ANDA078216 -
SPL ID
52ee1af5-9a84-797c-e063-6294a90ab63d -
SPL set ID
df8db06a-ced7-4dd6-83bd-c61d2f68f1b1 -
UNII
I1E9D14F36 -
RxCUI
200371 -
RxCUI
283672 -
RxCUI
309314
What the source publishes
- Labeler
- ASCLEMED USA INC.
- Active ingredients
- Citalopram
- Form
- TABLET, FILM COATED
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Citalopram",
"splId": "52ee1af5-9a84-797c-e063-6294a90ab63d",
"labels": [
{
"setId": "df8db06a-ced7-4dd6-83bd-c61d2f68f1b1",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=df8db06a-ced7-4dd6-83bd-c61d2f68f1b1",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=df8db06a-ced7-4dd6-83bd-c61d2f68f1b1"
}
],
"routes": [
"ORAL"
],
"labeler": "ASCLEMED USA INC.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "100 TABLET, FILM COATED in 1 BOTTLE (87063-221-01)",
"package_ndc": "87063-221-01",
"identifierStatus": "well-formed",
"marketing_start_date": "20260529"
},
{
"sample": false,
"description": "10 TABLET, FILM COATED in 1 BOTTLE (87063-221-10)",
"package_ndc": "87063-221-10",
"identifierStatus": "well-formed",
"marketing_start_date": "20260529"
},
{
"sample": false,
"description": "20 TABLET, FILM COATED in 1 BOTTLE (87063-221-20)",
"package_ndc": "87063-221-20",
"identifierStatus": "well-formed",
"marketing_start_date": "20260529"
},
{
"sample": false,
"description": "30 TABLET, FILM COATED in 1 BOTTLE (87063-221-30)",
"package_ndc": "87063-221-30",
"identifierStatus": "well-formed",
"marketing_start_date": "20260529"
},
{
"sample": false,
"description": "60 TABLET, FILM COATED in 1 BOTTLE (87063-221-60)",
"package_ndc": "87063-221-60",
"identifierStatus": "well-formed",
"marketing_start_date": "20260529"
},
{
"sample": false,
"description": "90 TABLET, FILM COATED in 1 BOTTLE (87063-221-90)",
"package_ndc": "87063-221-90",
"identifierStatus": "well-formed",
"marketing_start_date": "20260529"
}
],
"productId": "87063-221_52ee1af5-9a84-797c-e063-6294a90ab63d",
"useDomain": "unknown",
"dosageForm": "TABLET, FILM COATED",
"productNdc": "87063-221",
"deaSchedule": null,
"genericName": "Citalopram",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "CITALOPRAM HYDROBROMIDE",
"strength": "40 mg/1"
}
],
"applicationNumber": "ANDA078216",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20071018",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"unii": [
"I1E9D14F36"
],
"rxcui": [
"200371",
"283672",
"309314"
],
"spl_set_id": [
"df8db06a-ced7-4dd6-83bd-c61d2f68f1b1"
],
"manufacturer_name": [
"ASCLEMED USA INC."
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:87063-221_52ee1af5-9a84-797c-e063-6294a90ab63d"